Sarepta Therapeutics, Inc. Stockholders Equity

Quick Answer

Sarepta Therapeutics, Inc. reported Stockholders Equity of $1.14 billion for the year ending 2025.

  • Sarepta Therapeutics, Inc. showed a decrease of -25.3% in Stockholders Equity from 2024 to 2025.
  • This data is from Sarepta Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q3 2013: $246.98 million | Q1 2014: $228.96 million | Q2 2014: $299.92 million | Q3 2014: $286.20 million | Q1 2015: $200.76 million | Q2 2015: $165.38 million | Q3 2015: $123.24 million | Q1 2016: $138.96 million | Q2 2016: $121.46 million | Q3 2016: $408.62 million | Q1 2017: $429.14 million | Q2 2017: $377.77 million | Q3 2017: $697.16 million | Q1 2018: $776.76 million | Q2 2018: $699.05 million | Q3 2018: $639.85 million | Q1 2019: $1.35 billion | Q2 2019: $1.10 billion | Q3 2019: $995.20 million | Q1 2020: $1.14 billion | Q2 2020: $1.04 billion | Q3 2020: $892.05 million | Q1 2021: $535.45 million | Q2 2021: $485.11 million | Q3 2021: $469.53 million | Q1 2022: $856.89 million | Q2 2022: $726.46 million | Q3 2022: $430.84 million | Q1 2023: $712.75 million | Q2 2023: $741.41 million | Q3 2023: $764.36 million | Q1 2024: $961.19 million | Q2 2024: $1.08 billion | Q3 2024: $1.22 billion | Q1 2025: $1.14 billion | Q2 2025: $1.36 billion | Q3 2025: $1.32 billion.
  • Over the full 16 years of available data (2010 to 2025), Sarepta Therapeutics, Inc.'s Stockholders Equity has grown by 40,590.7%.
  • Historical annual values: Fiscal year 2025: $1.14 billion | Fiscal year 2024: $1.53 billion | Fiscal year 2023: $859.34 million | Fiscal year 2022: $384.95 million | Fiscal year 2021: $928.01 million | Fiscal year 2020: $761.76 million | Fiscal year 2019: $818.19 million | Fiscal year 2018: $1.03 billion | Fiscal year 2017: $789.22 million | Fiscal year 2016: $336.69 million | Fiscal year 2015: $190.35 million | Fiscal year 2014: $247.65 million | Fiscal year 2013: $247.19 million | Fiscal year 2012: $123.68 million | Fiscal year 2011: $31.02 million | Fiscal year 2010: -$2.82 million.
  • Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: